The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral hernia.
It was reported that after the overlay implant, the patient experienced bowel perforation, adhesions, dilated small bowel, inflammation, purulent material, attenuated fascia, erythema, recurrence, and cellulitis.
Post-operative patient treatment included revision surgery, resection of perforated small intestine, ileostomy/hartmann procedure, primary closure of fascia, wound left open/packed with gauze, post-operatively in serious condition, prolonged hospitalization, and bowel resection.
|